Inogen
INGN
149 hedge funds and large institutions have $723M invested in Inogen in 2022 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 57 increasing their positions, 45 reducing their positions, and 35 closing their positions.
89% more call options, than puts
Call options by funds: $496K | Put options by funds: $263K
27% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 45
2.34% more ownership
Funds ownership: 96.06% → 98.4% (+2.3%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
3% less capital invested
Capital invested by funds: $742M → $723M (-$19.1M)
11% less funds holding
Funds holding: 168 → 149 (-19)
54% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 35
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$17.3M |
| 2 |
FAM
Fred Alger Management
New York
|
+$10.1M |
| 3 |
SCM
Sio Capital Management
New York
|
+$9.8M |
| 4 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
+$7.12M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$6.98M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JGC
J. Goldman & Co
New York
|
-$5.1M |
| 2 |
AI
Acuitas Investments
Seattle,
Washington
|
-$5.09M |
| 3 |
JP Morgan Chase
New York
|
-$4.38M |
| 4 |
Millennium Management
New York
|
-$3.63M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$3.62M |
INGN Hedge Fund Activity: Q1 2022 in Review
149 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Inogen (INGN) for Q1 2022, worth a combined $723M — down 2.6% from $742M a quarter earlier.
Sellers outnumbered buyers: 35 funds closed out of INGN and 16 opened new positions — a net loss of 19 holders — while 45 trimmed existing stakes and 57 added.
The largest buyer was Camber Capital Management, adding an estimated $17.3M. The largest seller was J. Goldman & Co, exiting entirely with an estimated $5.1M sold.
- 149 institutional investors held Inogen (INGN) as of Q1 2022, down from 168 in Q4 2021.
- Funds reported $723M of Inogen stock for Q1 2022, down 2.6% quarter-over-quarter.
- 16 funds opened new Inogen positions in Q1 2022 and 35 closed out, a net change of -19 holders.
- The largest Inogen buyer in Q1 2022 was Camber Capital Management, an estimated $17.3M added.
- The largest Inogen seller in Q1 2022 was J. Goldman & Co, an estimated $5.1M sold.
Based on aggregated 13F filings for Q1 2022.